Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach-Reference-Cited by-同舟云学术

Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach

Published:2024-07-22 Issue:3 Volume:169 Page:633-646
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Fernandez-Gil Beatriz I.^ORCID,Schiapparelli Paula^ORCID,Navarro-Garcia de Llano Juan P.^ORCID,Otamendi-Lopez Andrea,Ulloa-Navas Maria Jose,Michaelides Loizos,Vazquez-Ramos Carla A.,Herchko Steven M.,Murray Melissa E.^ORCID,Cherukuri Yesesri,Asmann Yan W.,Trifiletti Daniel M.^ORCID,Quiñones-Hinojosa Alfredo^ORCID

Funder

Distinguished Mayo Clinic Investigator Award

William J. and Charles H. Mayo Professorship

the State of Florida Cancer Research Chair

Uihlein Neuro-oncology Research Fund

National Institutes of Health

Eveleigh Family Career Development Award for Cancer Research at Mayo Clinic in Florida

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11060-024-04765-5.pdf

Reference68 articles.

1. Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D, Hammack J, Ortiz K, Lesser E, Spiegel M, Prevatt C, Hawayek M, Quinones-Hinojosa A, Chaichana KL (2020) Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol 147:297–307. https://doi.org/10.1007/s11060-020-03451-6

2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987–996 https://doi.org/10.1056/NEJMoa043330

3. Ramos-Fresnedo A, Pullen MW, Perez-Vega C, Domingo RA, Akinduro OO, Almeida JP, Suarez-Meade P, Marenco-Hillembrand L, Jentoft ME, Bendok BR, Trifiletti DM, Chaichana KL, Porter AB, Quinones-Hinojosa A, Burns TC, Kizilbash SH, Middlebrooks EH, Sherman WJ (2022) The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. J Neurooncol 157:177–185. https://doi.org/10.1007/s11060-022-03960-6

4. Waqar M, Trifiletti DM, McBain C, O’Connor J, Coope DJ, Akkari L, Quinones-Hinojosa A, Borst GR (2022) Early therapeutic interventions for newly diagnosed Glioblastoma: Rationale and Review of the literature. Curr Oncol Rep 24:311–324. https://doi.org/10.1007/s11912-021-01157-0

5. Salazar OM, Rubin P, McDonald JV, Feldstein ML (1976) High dose radiation therapy in the treatment of glioblastoma multiforme: a preliminary report. Int J Radiat Oncol Biol Phys 1:717–727. https://doi.org/10.1016/0360-3016(76)90155-3